SunBio, Inc.
Founded in 1997 and KOSDAQ-listed in 2022, SunBio develops PEG derivatives including PEG-filgrastim, MucoPEG, and artificial blood SBX.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1997, SunBio, Inc. listed on KOSDAQ in 2022 and develops PEG (Polyethylene glycol) derivative materials. It manufactures the PEG derivative mPEG-PAL, exported to Intas Pharma for finished-product manufacturing in exchange for royalties, and applies its PEG technology to the neutropenia treatment PEG-filgrastim, the dry-mouth treatment MucoPEG, and the artificial blood substitute SBX. PEG derivative products account for 62% of revenue and technology royalties for 38%, with PEG-filgrastim sold in the EU, Canada, Australia, and India, and MucoPEG holding US marketing approval.
Products & technology
- PEG-filgrastimNeutropenia treatment
- mPEG-PALPEG derivative raw material used in PEG-filgrastim production, exported to Intas Pharma
- MucoPEGDry mouth (xerostomia) treatment
- Artificial blood SBXArtificial blood substitute
- PEG derivativesProduction and sale of PEG derivatives
Regulatory approvals
openFDA1 US FDA 510(k) · 2019
- FDAMucoPEG2019-11-05
R&D and key agreements
Source: DART corporate disclosure인공혈액 SBX · 출혈 및 수혈, 암모델 등 · 전임상(독성시험 완료, 동물효능시험 진행중) · Preclinical toxicity testing completed at Charles River Laboratories (US)
LNP 안정화 기술 플랫폼 · 백신, 암치료제 등 LNP제형 · 개발 및 시험중 · Technology that coats existing LNP formulations with a protective layer without altering them
이차전지 고체전해질(PEG 기술 기반) · 리튬이차전지 · 연구단계, 국내특허 2건 출원완료 · One-year joint research with University of Seoul lab; test results showed ionic conductivity and charge-discharge stability twice that of existing technology
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition